021-51111890
购物车（）
sales@molnova.cn
Deltorphin I(TFA)
CAS No. 122752-15-2
Deltorphin I(TFA) ( Deltorphin 1 | Deltorphin C )
产品货号. M21043 CAS No. 122752-15-2
Deltorphin I(TFA) 是 δ-阿片受体的激动剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥938 | 有现货 |
|
| 10MG | ￥1482 | 有现货 |
|
| 25MG | ￥2465 | 有现货 |
|
| 50MG | ￥3599 | 有现货 |
|
| 100MG | ￥4977 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥1416 | 有现货 |
|
生物学信息
-
产品名称Deltorphin I(TFA)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Deltorphin I(TFA) 是 δ-阿片受体的激动剂。
-
产品描述Deltorphin I(TFA) is an agonist of δ-opioid receptor.
-
体外实验——
-
体内实验Twice daily administration of Deltorphin I (20μg/mouse) for 4 days produces tolerance to Deltorphin I analgesia, as shown by the decrease in the analgesic response. The peak analgesic response to Deltorphin I (20 μg/mouse) at 10 min after injections is decreased from 8.36±0.28 s (the 1st day) to 4.53±0.14 s (the 4th day) markedly. Concurrent treatment of Melatonin (0.5, 1 and 2.5 mg/kg) and Deltorphin I (20 μg/mouse) twice daily for 4 days can attenuate the tolerance to Deltorphin I analgesia (P<0.05, <0.05 and <0.05), and this effect is dose dependent.
-
同义词Deltorphin 1 | Deltorphin C
-
通路Endocrinology/Hormones
-
靶点Opioid Receptor
-
受体δ-opioid receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number122752-15-2
-
分子量768.86
-
分子式C37H52N8O10
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 25 mg/mL (32.52 mM)
-
SMILESCC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Dupin S Tafani J A M Honoré Mazarguil et al. [125I][D-Ala2]deltorphin-I: A high affinity delta-selective opioid receptor ligand[J]. Peptides 1991 12(4):825-830.
产品手册
关联产品
-
NKTR-181
一种新型、长效、口服活性、选择性 mu-阿片类激动剂。
-
Gluten Exorphin B5
Gluten exorphin B5 (GE-B5) is a food-derived opioid peptide identified in digests of wheat gluten.
-
CTAP
Potent and selective μ opioid receptor antagonist (IC50 = 3.5 nM). Displays > 1200-fold selectivity over δ opioid and somatostatin receptors. Brain penetrant and active in vivo.
